Table 2.
Ki-67 Index |
No. of Cases |
p53 | p16 | Rsf-1 | Cyclin E | FASN |
---|---|---|---|---|---|---|
<10% | 8 | 5/8 (63%) | 3/7(43%) | 3/7 (43%) | 5/8 (63%) | 5/8 (63%) |
10-49% | 14 | 13/14 (93%) | 6/14 (43%) | 10/13 (77%) | 6/13 (46%) | 7/14 (50%) |
≥ 50% | 15 | 14/14 (100%) | 9/12 (75%) | 9/15 (60%) | 13/14 (93%) | 11/15 (73%) |
total | 37 | 32/36 (89%) | 18/33 (55%) | 22/35 (63%) | 24/35 (77%) | 23/37 (62%) |
For p53 a case was considered positive if the intensity score was 0 or ≥50% (intense nuclear) since both of these patterns are associated with TP53 mutations. Increased expression for p16 was defined as ≥ 50% of positive cells, for cyclin E ≥ 10% of positive cells, for Rsf-1 ≥ 1 (final score) and for FASN ≥ 1 (final score). The final score for Rsf-1 and FASN was determined by subtracting the intensity of the stain in normal adjacent tubal epithelium from the initial intensity score in the STIC.